Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharmaceutical companies that have received venture funding. This month’s column covers deals announced in August 2017.
Neurodegenerative disease-focused Alzeca Biosciences Inc., which is working on MRI-based targeted contrast agents to diagnose early-stage Alzheimer’s disease, closed...








